Back to Search
LEKSHMI NAIR, MD
MD
Internal Medicine Physician
NPI: 1245677319IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
036141105(IL)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
Aerosol based detectors for the investigation of phospholipid hydrolysis in a pharmaceutical suspension formulation.
PMID 19070982·J Pharm Biomed Anal·2009
8-other
Nanofibers and nanoparticles for orthopaedic surgery applications.
PMID 18292367·J Bone Joint Surg Am·2008
6-review
Comparison of electrospray ionization mass spectrometry and evaporative light scattering detections for the determination of Poloxamer 188 in itraconazole injectable formulation.
PMID 16458475·J Pharm Biomed Anal·2006
4-observational
Synthesis, characterization, and osteocompatibility evaluation of novel alanine-based polyphosphazenes.
PMID 16265637·J Biomed Mater Res A·2006
7-preclinical
Polymers as biomaterials for tissue engineering and controlled drug delivery.
PMID 17089786·Adv Biochem Eng Biotechnol·2006
6-review
Development of novel tissue engineering scaffolds via electrospinning.
PMID 15155157·Expert Opin Biol Ther·2004
6-review
Determination of polysorbate 80 in parenteral formulations by high-performance liquid chromatography and evaporative light scattering detection.
PMID 14509344·J Chromatogr A·2003
8-other
Biomimetic, bioactive etheric polyphosphazene-poly(lactide-co-glycolide) blends for bone tissue engineering.
PMID 19165780·J Biomed Mater Res A·2010
7-preclinical
Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties.
PMID 19473187·Clin Exp Pharmacol Physiol·2009
7-preclinical
The influence of side group modification in polyphosphazenes on hydrolysis and cell adhesion of blends with PLGA.
PMID 19345410·Biomaterials·2009
7-preclinical
Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
PMID 19481946·Bioorg Med Chem·2009
7-preclinical
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
PMID 19196021·J Med Chem·2009
7-preclinical
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
PMID 19456105·J Med Chem·2009
7-preclinical
Markers of fetal onset adult diseases: a comparison among low birthweight and normal birthweight adolescents.
PMID 19279368·Indian Pediatr·2009
4-observational
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
PMID 19102654·J Med Chem·2009
8-other
Fabrication, characterization, and in vitro evaluation of poly(lactic acid glycolic acid)/nano-hydroxyapatite composite microsphere-based scaffolds for bone tissue engineering in rotating bioreactors.
PMID 19030184·J Biomed Mater Res A·2009
8-other
Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings.
PMID 19168351·Bioorg Med Chem Lett·2009
7-preclinical
Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid).
PMID 17942150·Biomaterials·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 676 N SAINT CLAIR ST STE 415
CHICAGO, IL 60611 - Phone
- (312) 926-3627
Quick Facts
- NPI
- 1245677319
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile